BHCM
ZURA icon

Brevan Howard Capital Management’s Zura Bio ZURA Stock Holding History

Brevan Howard Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-72,038
Closed -$429K – 2645
2026
Q1 		$429K Buy
+72,038
New +$435K ﹤0.01% 1395

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Brevan Howard Capital Management's ZURA Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 72,038 shares — an estimated $429K sold.

Brevan Howard Capital Management first reported a position in ZURA in Q1 2026 and held it in 1 quarter. The position peaked at $429K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 72,038 Zura Bio shares in Q2 2026, an estimated $429K.
  • Brevan Howard Capital Management first reported a position in Zura Bio in Q1 2026 and held it in 1 quarter.
  • Brevan Howard Capital Management's Zura Bio position peaked at $429K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.